DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Rozerem (Ramelteon) - Summary

 


Nutrilib.com
A comprihensive source of nutritional information

ROZEREM SUMMARY

ROZEREM™ (ramelteon) is an orally active hypnotic chemically designated as (S)- N -[2-(1,6,7,8-tetrahydro-2 H -indeno-[5,4- b ]furan-8-yl)ethyl]propionamide and containing one chiral center.

ROZEREM is indicated for the treatment of insomnia characterized by difficulty with sleep onset.


See all Rozerem indications & dosage >>

ROZEREM NEWS HIGHLIGHTS

Media Articles Related to Rozerem (Ramelteon)

Novel Insomnia Drug Shows Promise for Jet Lag
Source: MedPageToday.com - medical news plus CME for physicians [2008.12.01]

Insomnia drug helps jet-lag, shift-work troubles (Reuters)
Source: Y! Health News Search RSS Feed [2008.12.01]

Health Tip: Treating Insomnia
Source: MedicineNet Sleep Specialty [2008.11.17]

Primary Insomnia Tied to Brain Neurochemical Imbalance
Source: MedicineNet Sleep Aids And Stimulants Specialty [2008.11.04]

Primary Insomnia And A Neurochemical Abnormality In Young And Middle-Aged Adults Linked By Study
Source: Sleep / Sleep Disorders / Insomnia News From Medical News Today [2008.11.03]

more >>

Published Studies Related to Rozerem (Ramelteon)

Ramelteon 8 mg/d versus placebo in patients with chronic insomnia: post hoc analysis of a 5-week trial using 50% or greater reduction in latency to persistent sleep as a measure of treatment effect. [2008.07]

Self-reported efficacy and tolerability of ramelteon 8 mg in older adults experiencing severe sleep-onset difficulty. [2007.09]

Evaluation of the efficacy and safety of ramelteon in subjects with chronic insomnia. [2007.08.15]

Ramelteon for the treatment of insomnia. [2006.10]

Effects of ramelteon on patient-reported sleep latency in older adults with chronic insomnia. [2006.06]

more >>

Clinical Trials Related to Rozerem (Ramelteon)

A Study to Evaluate the Ability of Ramelteon to Alleviate the Insomnia Symptoms Associated With Eastward Bound Jet Lag in Healthy Adult Volunteers [Completed]

A Study to Evaluate the Phase-Shifting Effects of Repeated Daily Dosing of TAK-375 in Healthy Subjects [Completed]

Treatment of Subjects With Mild to Moderate Alzheimer's Disease and Sleep Treatment of Subjects Who Have Mild to Moderate Alzheimer's Disease and Sleep Disturbance With Rozeremâ„¢ [Completed]

A Safety and Efficacy Study of TAK-375 in Adults With Chronic Insomnia [Completed]

A Safety and Efficacy Outpatient Study of TAK-375 in Adults With Chronic Insomnia [Completed]

more >>

Page last updated: 2008-12-01

-- advertisement -- The American Red Cross

We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2008